Technical Analysis of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) for the period of 9-Day stands at 24.74% while the stochastic %D for the same period stands at 23.06%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)’s 20-Day Bollinger Band indicates “Sell”.

About Company

Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies.  Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments.  To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.

Previous Day Activity Analysis

On the last trading day, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) opened the session at $5.15 and after going down -5.88% closed at $4.8. The stock lost -0.35 points in the last trade.

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)’s stock fluctuated in the range of $4.41 and $5.15 during the previous active session. Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) traded with the volume of 1.68 Million with average volume of 521.86 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0.45 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.25 and 36.83 respectively.

Currently the Insider Ownership of the shares of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) is at 9.86% and the shares outstanding are 33.31 Million.

Important Ratio Analysis

Some important ratios to consider here for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) are discussed below:

Dividend yield of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 14.03 and 3.72 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 14.94 and 0 correspondingly.

The Quick Ratio of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) stands at 2 while the Current Ratio depicts the value of 2.2.

Return on Assets ROA of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) is at -51.1% whereas, Return on Equity ROE and Return of Investment ROI of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) stand at -74.2% and -63.1% respectively.

Stock Performance Analysis

The stock performance of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) on the basis of 5 day trade show the dip of -9% whereas, the monthly performance of the stock shows decrease of -7.69%.

The quarterly performance of the stock remained in red zone with the value of -8.57% while six month performance of the shares of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) remained bullish with the count of 5.49%.

The yearly and YTD performance of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) remained up at 67.83% and 52.38% respectively.